Latest News and Press Releases
Want to stay updated on the latest news?
-
LA JOLLA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar”) today announced that Mac Armstrong, Chairman and Chief Executive Officer, and Chris Uchida,...
-
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX–V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) and Dundee Corporation (TSX: DC.A) (“Dundee”) are...
-
Castle announced the publication of a validation study in the Journal of the American Academy of Dermatology for its AdvanceAD-Tx test.
-
VANCOUVER, British Columbia, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) is pleased to announce that the Company’s shareholders...
-
VANCOUVER, British Columbia, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) is pleased to report the start of drilling at the...
-
Forrester Consulting Total Economic Impact™ study found Dayforce customers achieved 176% ROI and $6.8 million in NPV over 3 years.
-
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...
-
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Product of the Year Canada, the world’s largest globally recognized consumer-voted award for product innovation, today announces the 2026 Product of the...
-
LA JOLLA, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $56.2 million, or $2.06 per diluted share, for the fourth...
-
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...